clobetasol propionate + methotrexate

Clobetasol propionate + methotrexate is a combination of two pharmaceutical agents used primarily in dermatology, especially for the treatment of moderate-to-severe plaque psoriasis and other corticosteroid-responsive dermatoses. Clobetasol propionate is a very potent topical corticosteroid that acts as an anti-inflammatory, antipruritic, and vasoconstrictive agent by binding to the glucocorticoid receptor and modulating gene expression to suppress inflammatory pathways. Methotrexate is an antimetabolite and antifolate small molecule that inhibits dihydrofolate reductase, leading to suppression of DNA synthesis in rapidly dividing cells such as those involved in immune responses. The combination may be used when monotherapy with either agent is insufficient or when a steroid-sparing effect is desired. This regimen can provide enhanced efficacy for conditions like psoriasis while potentially reducing systemic side effects associated with higher doses of either drug alone[5][7].